miR-150 Suppresses the Proliferation and Tumorigenicity of Leukemia Stem Cells by Targeting the Nanog Signaling Pathway
Authors:
Open Access
- 18 November 2016
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 7, 439
Abstract
Proliferation, a key feature of cancer cells, accounts for the majority of cancer-related diseases resulting in mortality. MicroRNAs (miRNAs) plays important post-transcriptional modulation roles by acting on multiple signaling pathways, but the underlying mechanism in proliferation and tumorigenicity is unclear. Here, we identified the role of miR-150 in proliferation and tumorigenicity in leukemia stem cells (LSCs) (CD34+CD38- cells). miR-150 expression was significantly down-regulated in LSCs from leukemia cell lines and clinical samples. Functional assays demonstrated that increased miR-150 expression inhibited proliferation and clonal and clonogenic growth, enhanced chemosensitivity, and attenuated tumorigenic activity of LSCs in vitro. Transplantation animal studies revealed that miR-150 overexpression progressively abrogates tumour growth. Immunohistochemistry assays demonstrated that miR-150 overexpression enhanced caspase-3 level and reduced Ki-67 level. Moreover, luciferase reporter assays indicated Nanog is a direct and functional target of miR-150. Nanog silencing using small interfering RNA recapitulated anti-proliferation and tumorigenicity inhibition effects. Furthermore, miR-150 directly down-regulated the expression of other cancer stem cell factors including Notch2 and CTNNB1. These results provide insights into the specific biological behaviour of miR-150 in regulating LSC proliferation and tumorigenicity. Targeting this miR-150/Nanog axis would be a helpful therapeutic strategy to treat acute myeloid leukemia.Keywords
This publication has 62 references indexed in Scilit:
- Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding QuestionsStem Cells, 2015
- Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemiaMolecular Cytogenetics, 2013
- Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem‐like phenotype through modulation of the PI3K/Akt/β‐catenin/CBP pathwayInternational Journal of Cancer, 2013
- Characteristics of Notch2+ pancreatic cancer stem‐like cells and the relationship with centroacinar cellsCell Biology International, 2013
- Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinomaHepatology, 2012
- Coexpression of Oct4 and Nanog Enhances Malignancy in Lung Adenocarcinoma by Inducing Cancer Stem Cell–Like Properties and Epithelial–Mesenchymal TransdifferentiationCancer Research, 2010
- Down-Regulation of hsa-miR-10a in Chronic Myeloid Leukemia CD34+ Cells Increases USF2-Mediated Cell GrowthMolecular Cancer Research, 2008
- miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurelyProceedings of the National Academy of Sciences, 2007
- Core Transcriptional Regulatory Circuitry in Human Embryonic Stem CellsCell, 2005
- Human AML cells in NOD/SCID mice: engraftment potential and gene expressionLeukemia, 2002